Form 8-K Syndax Pharmaceuticals For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- US considers new sanctions on Brazilian judge, FT reports
- Six dead in 'stampede-like' incident at India temple, ANI says
Syndax Pharmaceuticals (SNDX) PT Raised to $51 at Citi, Opens 90d Catalyst Watch
August 5, 2025 11:15 AM EDTCiti analyst Yigal Nochomovitz raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $51.00 (from $46.00) while maintaining a Buy rating.
Opens 90-Day Upside Catalyst Watch ahead of October 25 PDUFA for Revuforjs sNDA in R/R mNPM1 AML.... More